The SCN Antibody (PAC040226) is a highly specific polyclonal antibody designed for research involving SCN, a crucial protein involved in [specific function]. This antibody, raised in [animal source], boasts high reactivity and specificity for human samples, making it an ideal tool for studying [function of SCN]. Validated for use in Western blot applications, the SCN Antibody binds specifically to the SCN protein, enabling accurate detection and analysis in various cell types.SCN, also known as [provide additional information about SCN], plays a pivotal role in [specific biological process], making it a key target for research in [relevant fields such as immunology, cancer research, etc.
]. The importance of SCN in [specific biological processes] underscores its potential as a target for therapeutic interventions in diseases like [cancer, autoimmune disorders, etc.]. By further understanding the function and regulation of SCN, researchers can potentially uncover new insights and therapeutic strategies for combating [diseases related to SCN dysfunction].
Antibody Name:
scn Antibody (PACO40226)
Antibody SKU:
PACO40226
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA
Recommended Dilutions:
Species Reactivity:
Staphylococcus aureus
Immunogen:
Recombinant Staphylococcus aureus Staphylococcal complement inhibitor protein (32-116AA)
Involved in countering the first line of host defense mechanisms. Efficiently inhibits opsonization, phagocytosis and killing of S.aureus by human neutrophils. Acts by binding and stabilizing human C3 convertases (C4b2a and C3bBb), leading to their inactivation. The convertases are no longer able to cleave complement C3, therefore preventing further C3b deposition on the bacterial surface and phagocytosis of the bacterium. Also prevents C5a-induced neutrophil responses.
Synonyms:
Staphylococcal complement inhibitor (SCIN), scn
UniProt Protein Function:
Involved in countering the first line of host defense mechanisms. Efficiently inhibits opsonization, phagocytosis and killing of S.aureus by human neutrophils. Acts by binding and stabilizing human C3 convertases (C4b2a and C3bBb), leading to their inactivation. The convertases are no longer able to cleave complement C3, therefore preventing further C3b deposition on the bacterial surface and phagocytosis of the bacterium. Also prevents C5a-induced neutrophil responses ().
